ISPOR - Budget Impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple Sclerosis

Full Text

Budget Impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple Sclerosis

Abstract

Authors

JA Mauskopf J Graham M Fay-Azhar E Kinter

Back to Volume 18, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now